BR112017003663A2 - composto, composição, e, método para tratamento de infecção por hiv. - Google Patents
composto, composição, e, método para tratamento de infecção por hiv.Info
- Publication number
- BR112017003663A2 BR112017003663A2 BR112017003663A BR112017003663A BR112017003663A2 BR 112017003663 A2 BR112017003663 A2 BR 112017003663A2 BR 112017003663 A BR112017003663 A BR 112017003663A BR 112017003663 A BR112017003663 A BR 112017003663A BR 112017003663 A2 BR112017003663 A2 BR 112017003663A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- composition
- hiv infection
- compounds
- treating hiv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462042300P | 2014-08-27 | 2014-08-27 | |
PCT/US2015/046648 WO2016033009A1 (en) | 2014-08-27 | 2015-08-25 | Imidazo[1,2-a]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017003663A2 true BR112017003663A2 (pt) | 2017-11-28 |
Family
ID=54064588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017003663A BR112017003663A2 (pt) | 2014-08-27 | 2015-08-25 | composto, composição, e, método para tratamento de infecção por hiv. |
Country Status (13)
Country | Link |
---|---|
US (1) | US10065953B2 (pt) |
EP (1) | EP3186254B1 (pt) |
JP (1) | JP2017526748A (pt) |
KR (1) | KR20170045308A (pt) |
CN (1) | CN107001357A (pt) |
AU (1) | AU2015306779B2 (pt) |
BR (1) | BR112017003663A2 (pt) |
CA (1) | CA2958591A1 (pt) |
CL (1) | CL2017000428A1 (pt) |
IL (1) | IL250561A0 (pt) |
RU (1) | RU2017107715A (pt) |
WO (1) | WO2016033009A1 (pt) |
ZA (1) | ZA201701214B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9975906B2 (en) | 2014-05-16 | 2018-05-22 | Shionogi & Co., Ltd. | Tricyclic heterocycle derivatives having HIV replication inhibitory effect |
TWI700284B (zh) | 2015-05-29 | 2020-08-01 | 日商塩野義製藥股份有限公司 | 具有hiv複製抑制作用之含氮3環性衍生物 |
CN109232562A (zh) * | 2018-10-24 | 2019-01-18 | 康化(上海)新药研发有限公司 | 一种7-氮杂吲哚-5-氯-6-羧酸的合成方法 |
CN113195475A (zh) * | 2018-10-24 | 2021-07-30 | Viiv保健英国第五有限公司 | 人免疫缺陷病毒复制的抑制剂 |
PE20212074A1 (es) | 2019-03-22 | 2021-10-26 | Gilead Sciences Inc | Compuestos de carbamoyl piridona triciclicos con puente y su uso farmaceutico |
MX2022009871A (es) | 2020-02-24 | 2022-08-19 | Gilead Sciences Inc | Compuestos tetraciclicos para tratar la infeccion por el virus de la inmunodeficiencia humana (vih). |
HUE064467T2 (hu) | 2021-01-19 | 2024-03-28 | Gilead Sciences Inc | Szubsztituált piridotriazin-származékok és alkalmazásuk |
TWI843506B (zh) | 2022-04-06 | 2024-05-21 | 美商基利科學股份有限公司 | 橋聯三環胺甲醯基吡啶酮化合物及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8338441B2 (en) * | 2009-05-15 | 2012-12-25 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
US8633200B2 (en) * | 2010-09-08 | 2014-01-21 | Bristol-Myers Squibb Company | Inhibitors of human immunodeficiency virus replication |
ES2615734T3 (es) * | 2011-04-21 | 2017-06-08 | Gilead Sciences, Inc. | Compuestos de benzotiazol y su uso farmacéutico |
US9034882B2 (en) * | 2012-03-05 | 2015-05-19 | Bristol-Myers Squibb Company | Inhibitors of human immunodeficiency virus replication |
BR112014018990A8 (pt) * | 2012-04-20 | 2017-07-11 | Gilead Sciences Inc | Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção |
ES2623777T3 (es) * | 2013-03-13 | 2017-07-12 | VIIV Healthcare UK (No.5) Limited | Inhibidores de la replicación del virus de la inmunodeficiencia humana |
-
2015
- 2015-08-25 US US15/505,955 patent/US10065953B2/en not_active Expired - Fee Related
- 2015-08-25 EP EP15760003.2A patent/EP3186254B1/en active Active
- 2015-08-25 RU RU2017107715A patent/RU2017107715A/ru not_active Application Discontinuation
- 2015-08-25 WO PCT/US2015/046648 patent/WO2016033009A1/en active Application Filing
- 2015-08-25 CA CA2958591A patent/CA2958591A1/en not_active Abandoned
- 2015-08-25 BR BR112017003663A patent/BR112017003663A2/pt not_active IP Right Cessation
- 2015-08-25 CN CN201580058209.6A patent/CN107001357A/zh active Pending
- 2015-08-25 JP JP2017530959A patent/JP2017526748A/ja active Pending
- 2015-08-25 AU AU2015306779A patent/AU2015306779B2/en not_active Ceased
- 2015-08-25 KR KR1020177008130A patent/KR20170045308A/ko unknown
-
2017
- 2017-02-12 IL IL250561A patent/IL250561A0/en unknown
- 2017-02-17 ZA ZA2017/01214A patent/ZA201701214B/en unknown
- 2017-02-22 CL CL2017000428A patent/CL2017000428A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2017526748A (ja) | 2017-09-14 |
EP3186254A1 (en) | 2017-07-05 |
WO2016033009A1 (en) | 2016-03-03 |
RU2017107715A (ru) | 2018-09-27 |
KR20170045308A (ko) | 2017-04-26 |
AU2015306779A1 (en) | 2017-03-16 |
US20180222901A1 (en) | 2018-08-09 |
IL250561A0 (en) | 2017-03-30 |
US10065953B2 (en) | 2018-09-04 |
AU2015306779B2 (en) | 2017-11-02 |
RU2017107715A3 (pt) | 2019-03-04 |
CN107001357A (zh) | 2017-08-01 |
EP3186254B1 (en) | 2019-03-06 |
CA2958591A1 (en) | 2016-03-03 |
CL2017000428A1 (es) | 2017-08-18 |
ZA201701214B (en) | 2019-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017003663A2 (pt) | composto, composição, e, método para tratamento de infecção por hiv. | |
BR112018009252A2 (pt) | tratamento da osteoartrite | |
EA201800367A1 (ru) | Способы лечения болезни хантингтона | |
CR20160564A (es) | Dinucleótidos cíclicos como moduladores de sting | |
EA201792069A1 (ru) | Производные азокана и азонана и способы лечения инфекций гепатита в | |
EA201691261A1 (ru) | Новые дигидрохинолизиноны для лечения и профилактики инфекции, вызванной вирусом гепатита b | |
MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
MX2019009932A (es) | Derivados de quinazolina usados para tratar el virus de inmunodeficiencia humana (vih). | |
EA201790389A1 (ru) | Пирролопиримидиновые соединения, используемые в качестве агониста tlr7 | |
BR112017022544A2 (pt) | ?composto, composição, e, método para tratamento de infecção por hiv?. | |
MX2016013689A (es) | Compuestos 4-amino-imidazoquinolina. | |
JOP20180008A1 (ar) | مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b | |
EA201691440A1 (ru) | Производные азепана и способы лечения инфекций гепатита в | |
MX2020001757A (es) | Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades. | |
EA201691579A1 (ru) | Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b | |
EA201691726A1 (ru) | Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b | |
EA201990044A1 (ru) | Гетероциклические соединения в качестве антибактериальных средств | |
TW201613885A (en) | Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication | |
EA201590358A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
CL2018000688A1 (es) | Compuestos heterociclicos que contienen bencilamina y composiciones útiles contra infección por micobacterias | |
EA201690687A1 (ru) | Ингибиторы репликации вируса иммунодефицита | |
EA201791182A1 (ru) | Новые производные 2'- и/или 5'-аминокислотных эфиров фосфороамидатов 3'-дезоксиаденозина в качестве противораковых соединений | |
PH12017500533A1 (en) | 1-alkyl-6-oxo-1, 6-dihydropyridin-3-yl compounds and use as sgrm modulators | |
BR112017011422A2 (pt) | compostos de ácido isoazol hidro¬xâmico como inibidores de lpxc | |
GEP20227353B (en) | Tetracyclic heterocycle compounds useful as hiv integrase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2595 DE 29-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |